Synopsis
0
JDMF
0
KDMF
0
VMF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Certificate Number : CEP 2006-044 - Rev 07
Status : Valid
Issue Date : 2025-06-27
Type : Chemical
Substance Number : 1970
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.
CAS Number : 64228-78-0
End Use API : Atracurium Besylate
About The Company : Synnat Pharma is a fast-growing pharmaceutical company focused on the development, identification, production, and distribution of phytochemicals and botanical ...
Suanfarma, at the Core of a Better Life.
CAS Number : 6429-04-5
End Use API : Atracurium Besylate
About The Company : Suanfarma is a B2B life sciences company focused on developing, manufacturing, and distributing high-quality ingredients for the pharmaceutical industry in an i...
Suanfarma, at the Core of a Better Life.
CAS Number : 54417-53-7
End Use API : Atracurium Besylate
About The Company : Suanfarma is a B2B life sciences company focused on developing, manufacturing, and distributing high-quality ingredients for the pharmaceutical industry in an i...
Suanfarma, at the Core of a Better Life.
CAS Number : 111-29-5
End Use API : Atracurium Besylate
About The Company : Suanfarma is a B2B life sciences company focused on developing, manufacturing, and distributing high-quality ingredients for the pharmaceutical industry in an i...
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
R-Tetrahydropapaverine N-acetyl-L-leucinate
CAS Number : 141109-12-8
End Use API : Atracurium Besylate
About The Company : Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square mete...
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
CAS Number : 54417-53-7
End Use API : Atracurium Besylate
About The Company : Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square mete...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Aspen API. More than just an API™
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Tracrium
Dosage Form : Injectable And Infusion Solution
Dosage Strength : 10MG
Packaging :
Approval Date : 01-09-1987
Application Number : 57335
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Tracrium
Dosage Form : Solution For Injection And Infusion
Dosage Strength : 10MG/ML
Packaging :
Approval Date : 2005-11-25
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Parenteral
Solubilizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
94
PharmaCompass offers a list of Atracurium Besylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Atracurium Besylate manufacturer or Atracurium Besylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Atracurium Besylate manufacturer or Atracurium Besylate supplier.
PharmaCompass also assists you with knowing the Atracurium Besylate API Price utilized in the formulation of products. Atracurium Besylate API Price is not always fixed or binding as the Atracurium Besylate Price is obtained through a variety of data sources. The Atracurium Besylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Atracurium Besylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Atracurium Besylate, including repackagers and relabelers. The FDA regulates Atracurium Besylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Atracurium Besylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Atracurium Besylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Atracurium Besylate supplier is an individual or a company that provides Atracurium Besylate active pharmaceutical ingredient (API) or Atracurium Besylate finished formulations upon request. The Atracurium Besylate suppliers may include Atracurium Besylate API manufacturers, exporters, distributors and traders.
click here to find a list of Atracurium Besylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Atracurium Besylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Atracurium Besylate active pharmaceutical ingredient (API) in detail. Different forms of Atracurium Besylate DMFs exist exist since differing nations have different regulations, such as Atracurium Besylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Atracurium Besylate DMF submitted to regulatory agencies in the US is known as a USDMF. Atracurium Besylate USDMF includes data on Atracurium Besylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Atracurium Besylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Atracurium Besylate suppliers with USDMF on PharmaCompass.
A Atracurium Besylate CEP of the European Pharmacopoeia monograph is often referred to as a Atracurium Besylate Certificate of Suitability (COS). The purpose of a Atracurium Besylate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Atracurium Besylate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Atracurium Besylate to their clients by showing that a Atracurium Besylate CEP has been issued for it. The manufacturer submits a Atracurium Besylate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Atracurium Besylate CEP holder for the record. Additionally, the data presented in the Atracurium Besylate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Atracurium Besylate DMF.
A Atracurium Besylate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Atracurium Besylate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Atracurium Besylate suppliers with CEP (COS) on PharmaCompass.
A Atracurium Besylate written confirmation (Atracurium Besylate WC) is an official document issued by a regulatory agency to a Atracurium Besylate manufacturer, verifying that the manufacturing facility of a Atracurium Besylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Atracurium Besylate APIs or Atracurium Besylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Atracurium Besylate WC (written confirmation) as part of the regulatory process.
click here to find a list of Atracurium Besylate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Atracurium Besylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Atracurium Besylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Atracurium Besylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Atracurium Besylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Atracurium Besylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Atracurium Besylate suppliers with NDC on PharmaCompass.
Atracurium Besylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Atracurium Besylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Atracurium Besylate GMP manufacturer or Atracurium Besylate GMP API supplier for your needs.
A Atracurium Besylate CoA (Certificate of Analysis) is a formal document that attests to Atracurium Besylate's compliance with Atracurium Besylate specifications and serves as a tool for batch-level quality control.
Atracurium Besylate CoA mostly includes findings from lab analyses of a specific batch. For each Atracurium Besylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Atracurium Besylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Atracurium Besylate EP), Atracurium Besylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Atracurium Besylate USP).
